Form D · Other Health Care
North Texas Renal Management VII, LLC
Dallas, TX · CIK 0001776102
Offering snapshot reported Apr 14, 2026 · SEC filing
- Reported sold
- $94.1K Offering amount: $2.54M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 31, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 14, 2026 | Initial | $94,100 | No comparison | 1 | SEC filing |
| May 10, 2019 | Initial | $675,000 | No comparison | 51 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-580436
Source: Form D, filed Apr 14, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Steven M. Gieser | Director, Executive |
| Steven M Gieser, M.D. | Director, Executive |
| Ali N/A Khalil | Director |
| Jyothsna M. Kodali | Director, Executive |
| Alexander Liang, M.D. | Director |
| Daniel M. Richey | Director |
| Joris M Schuller, Jr., M.D. | Director |
| Anupkumar Shetty, M.D. | Director, Executive |
| Geoffrey S. Walker | Director, Executive |
| Geoffrey Walker, M.D. | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
1505 Lbj Freeway Suite 700
Dallas, TX, 75234
Dallas, TX, 75234